UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk

Osteoporosis international, 2019-04, Vol.30 (4), p.705-720

2019

Volltextzugriff (PDF)

Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial

Osteoporosis international, 2015-02, Vol.26 (2), p.699-712

2015

Volltextzugriff (PDF)

Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density

Osteoporosis international, 2015-05, Vol.26 (5), p.1543-1554

2015

Volltextzugriff (PDF)

The Association of Bone Turnover Markers with Muscle Function, Falls, and Frailty in Older Women in Long-Term Care

Journal of Frailty & Aging, 2023-10, Vol.12 (4), p.284-290

2023

Volltextzugriff (PDF)

Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur

Osteoporosis international, 2018-02, Vol.29 (2), p.501-506

2018

Volltextzugriff (PDF)

Two Promoter Polymorphisms Regulating Interleukin-6 Gene Expression Are Associated with Circulating Levels of C-Reactive Protein and Markers of Bone Resorption in Postmenopausal Women

The journal of clinical endocrinology and metabolism, 2003-01, Vol.88 (1), p.255-259

2003

Volltextzugriff (PDF)

Does Zoledronic Acid Improve Appendicular Lean Mass in Older Women with Osteoporosis? A Sub-Analysis of a Randomized Clinical Trial

The Journal of Frailty & Aging, 2022, Vol.11 (4), p.420-425

2022

Volltextzugriff (PDF)

Cost-effectiveness of 3 versus 6 years of zoledronic acid treatment before bisphosphonate holiday for women with osteoporosis

Osteoporosis international, 2022, Vol.33 (1), p.229-238

2022

Volltextzugriff (PDF)

Short-Term Changes in Bone Turnover Markers and Bone Mineral Density Response to Parathyroid Hormone in Postmenopausal Women with Osteoporosis

The journal of clinical endocrinology and metabolism, 2006-04, Vol.91 (4), p.1370-1375

2006

Volltextzugriff (PDF)

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

Osteoporosis international, 2011-01, Vol.22 (1), p.27-35

2011

Volltextzugriff (PDF)

Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design

Osteoporosis international, 2009-07, Vol.20 (7), p.1107-1116

2009

Volltextzugriff (PDF)

impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer

Breast cancer research and treatment, 2011-01, Vol.125 (2), p.441-446

2011

Volltextzugriff (PDF)

Cost-effectiveness of five versus ten years of alendronate treatment prior to drug holiday for women with osteoporosis

Osteoporosis international, 2020-07, Vol.31 (7), p.1273-1282

2020

Volltextzugriff (PDF)

Alendronate and estrogen effects in postmenopausal women with low bone mineral density

The journal of clinical endocrinology and metabolism, 2000-02, Vol.85 (2), p.720-726

2000

Volltextzugriff (PDF)

Self-perception of fracture risk: what can it tell us?

Osteoporosis international, 2017-12, Vol.28 (12), p.3495-3500

2017

Volltextzugriff (PDF)

Bisphosphonate drug holidays

Osteoporosis international, 2019-12, Vol.30 (12), p.2525-2525

2019

Volltextzugriff (PDF)

Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women

The journal of clinical endocrinology and metabolism, 2000-10, Vol.85 (10), p.3537-3540

2000

Volltextzugriff (PDF)

How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey

Osteoporosis international, 2021-04, Vol.32 (4), p.611-617

2021

Volltextzugriff (PDF)

COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey

Osteoporosis international, 2021-04, Vol.32 (4), p.619-622

2021

Volltextzugriff (PDF)

Zoledronic acid and bone health in older adults with cognitive impairment

Osteoporosis international, 2022-01, Vol.33 (1), p.293-298

2022

Volltextzugriff (PDF)

The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: A 2-year trial

Bone (New York, N.Y.), 2010-03, Vol.46 (3), p.655-659

2010

Volltextzugriff (PDF)

Early Changes in Biochemical Markers of Bone Turnover Predict the Long‐Term Response to Alendronate Therapy in Representative Elderly Women: A Randomized Clinical Trial

Journal of bone and mineral research, 1998-09, Vol.13 (9), p.1431-1438

1998

Volltextzugriff (PDF)

Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review

Osteoporosis international, 2014-01, Vol.25 (1), p.23-49

2014

Volltextzugriff (PDF)

Vitamin D deficiency is associated with functional decline and falls in frail elderly women despite supplementation

Osteoporosis international, 2017-04, Vol.28 (4), p.1347-1353

2017

Volltextzugriff (PDF)

Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial

Osteoporosis international, 2015-06, Vol.26 (6), p.1857-1864

2015

Volltextzugriff (PDF)

1 – 25 von 1.054

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(891)
Mit Volltextzugriff
(836)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(566)
Life Sciences & Biomedicine
(498)
Humans
(391)
Biological And Medical Sciences
(219)
Female
(165)
Medical Sciences
(159)
Animals
(118)
Aged
(94)
Endocrinology & Metabolism
(88)
Middle Aged
(81)
Osteoporosis
(77)
Technology
(76)
Fundamental And Applied Biological Sciences. Psychology
(75)
Adult
(61)
General & Internal Medicine
(54)
Medicine, General & Internal
(48)
Mice
(48)
Orthopedics
(46)
Aged, 80 And Over
(42)
Risk Factors
(40)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk

Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial

Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density

The Association of Bone Turnover Markers with Muscle Function, Falls, and Frailty in Older Women in Long-Term Care

Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur

Two Promoter Polymorphisms Regulating Interleukin-6 Gene Expression Are Associated with Circulating Levels of C-Reactive Protein and Markers of Bone Resorption in Postmenopausal Women

Does Zoledronic Acid Improve Appendicular Lean Mass in Older Women with Osteoporosis? A Sub-Analysis of a Randomized Clinical Trial

Cost-effectiveness of 3 versus 6 years of zoledronic acid treatment before bisphosphonate holiday for women with osteoporosis

Short-Term Changes in Bone Turnover Markers and Bone Mineral Density Response to Parathyroid Hormone in Postmenopausal Women with Osteoporosis

Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW)

Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design

impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer

Cost-effectiveness of five versus ten years of alendronate treatment prior to drug holiday for women with osteoporosis

Alendronate and estrogen effects in postmenopausal women with low bone mineral density

Self-perception of fracture risk: what can it tell us?

Bisphosphonate drug holidays

Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women

How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey

COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey

Zoledronic acid and bone health in older adults with cognitive impairment

The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: A 2-year trial

Early Changes in Biochemical Markers of Bone Turnover Predict the Long‐Term Response to Alendronate Therapy in Representative Elderly Women: A Randomized Clinical Trial

Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review

Vitamin D deficiency is associated with functional decline and falls in frail elderly women despite supplementation

Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial

Aktive Filter

Suchergebnisse filtern